Kersten Dirk

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Jun 22, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 18, 2026Sell(S)47K$20.07$941K4.1M
Jun 17, 2026Sell(S)37K$20.14$754K4.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-277529) within minutes of acceptance. Every field above traces to the original document. Verify it directly: